Drug Inflammation

Otezla

Payments companies reported to CMS as associated with Otezla. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$24Massociated payments (2023-2025)
79,358clinicians with associated payments
2companies reporting

By year

2023 $8.1M
2024 $8.7M
2025 $6.8M

Payments reported as associated with Otezla, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Dermatology $9.8M
Rheumatology $3.1M
Family Medicine $2.2M
Physician Assistant $1.7M
Family $1.6M
Internal Medicine $1.6M

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Otezla

These are the largest totals companies reported as associated with Otezla. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jana Johnson Sioux Falls, SD Dermatology $308,824.20
Rebecca Smith Fort Mill, SC Dermatology $280,753.78
Omar Noor Somerset, NJ $256,904.12
Brian Forrest Apex, NC Family Medicine $239,636.74
Rajiv Nathoo Maitland, FL Dermatology $227,353.32
Rola Gharib Morgantown, WV Dermatology $222,991.01
Brian Keegan East Windsor, NJ Dermatology $194,792.77
Tamera Thoener Nashville, TN Family $188,160.70
George Lewitt Northbrook, IL Dermatology $181,692.14
David Altman Warren, MI Dermatology $181,193.94

Prescribed Otezla?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.